Table 3.
Characteristics | 5‑Fluorouracil/ Cisplatin (n = 63) |
Carboplatin/ Paclitaxel (n = 27) |
p-Value |
---|---|---|---|
Surgical outcomes | |||
Surgical complications | 0.43 | ||
Yes | 30 (48.4) | 15 (57.7) | |
No | 32 (51.6) | 11 (42.3) | |
Hospital stay, days, median (min, max) | 19 (7–87) | 15 (8–140) | 0.24 |
Intensive/intermediate care unit stay, days, median (min, max) | 7 (1–54) | 4 (1–115) | 0.01 |
Death within 30 days post-surgery | 1 (1.6) | 1 (3.7) | 0.53 |
Late toxicity | |||
Late dysphagia | 0.58 | ||
0 | 55 (87.3) | 18 (85.7) | |
1 | 6 (9.5) | 3 (11.1) | |
2 | 2 (3.2) | 0 | |
Dermatitis | 0.52 | ||
0 | 62 (98.4) | 27 (100.0) | |
1 | 1 (1.6) | 0 |